'Atypical' Parkinson's disease - sporadic

Kirsten E Zeuner1, Daniela Berg1

  • 1Department of Neurology, Christian-Albrechts-University Kiel, Kiel, Germany.

Insights

Diagnosing Parkinson's disease (PD) relies on clinical symptoms, but atypical presentations can complicate differential diagnosis. This review explores features that challenge typical PD diagnosis, aiding neurologists in accurate assessments.

Area of Science:

  • Neurology
  • Clinical Diagnostics

Background:

  • Parkinson's disease (PD) diagnosis remains primarily clinical.
  • The 2015 MDS Clinical Diagnostic Criteria standardize expert diagnostic processes for neurologists.
  • Criteria incorporate positive and negative features for diagnosis.

Purpose of the Study:

  • To support less experienced neurologists in achieving expert-level diagnostic accuracy for PD.
  • To discuss atypical symptom constellations complicating the differential diagnosis of PD versus atypical parkinsonism.
  • To illustrate additional considerations for achieving a correct diagnosis.

Main Methods:

  • Review of clinical characteristics and diagnostic criteria for Parkinson's disease.
  • Analysis of features that may exclude patients with typical PD, especially in early or late stages.
  • Discussion of atypical presentations including absence of typical motor symptoms, poor dopaminergic response, autonomic dysfunction, dystonia, postural instability, and cognitive impairment.

Main Results:

  • Certain clinical features can complicate the differential diagnosis between typical Parkinson's disease and atypical parkinsonism.
  • Atypical presentations, such as lack of combined motor symptoms or insufficient treatment response, challenge standard diagnostic criteria.
  • Specific symptoms like autonomic dysfunction, dystonia, postural instability, and cognitive impairment require careful consideration.

Conclusions:

  • Accurate diagnosis of Parkinson's disease requires careful evaluation of both typical and atypical clinical features.
  • Understanding challenging symptom constellations is crucial for differentiating PD from atypical parkinsonism.
  • Additional diagnostic considerations beyond standard criteria are necessary for complex cases.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
896
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K